Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Game changer for arthritis and anti-fibrosis drugs

12.11.2012
Discovery shows medications can treat inflammation without increasing risk for infection

In a discovery that can fundamentally change how drugs for arthritis, and potentially many other diseases, are made, University of Utah medical researchers have identified a way to treat inflammation while potentially minimizing a serious side effect of current medications: the increased risk for infection.

These findings provide a new roadmap for making powerful anti-inflammatory medicines that will be safer not only for arthritis patients but also for millions of others with inflammation-associated diseases, such as diabetes, traumatic brain injury, and inflammatory bowel disease, according to cardiologist Dean Y. Li, M.D., Ph.D., the U School of Medicine vice dean for research and HA and Edna Benning endowed professor of medicine who led the study. "This can change the way medication is made," he says. "If we can find a way to replace our most powerful drugs for arthritis, we might be able to develop another way to treat inflammation in other diseases that we've been unable to touch because of the danger of suppressing people's immune systems."

The research, funded by the National Institutes of Health (NIH) and published Sunday, Nov. 11, 2012, Nature online, provides the University the opportunity to explore commercializing the technology either through collaboration outside of the state with pharmaceutical companies or within the state via initiatives such as USTAR. The Utah Legislature established USTAR (Utah Science Technology and Research) initiative in 2006 to promote economic growth and high paying jobs through research at the U of U and Utah State University.

"This is just one example of many scientific opportunities for the University and USTAR to work together to benefit not only millions of patients but build medical innovations in Utah," says Li, who's also director of the U of U Molecular Medicine program.

Two Cellular Pathways

When the body undergoes trauma or gets an infection, it responds by releasing cytokines—proteins that enter cells and unleash a three-pronged attack to kill invading bugs, hype up the immune system, and cause inflammation. While inflammation fights infection, it also produces an undesired side effect by weakening blood vessels, which can lead to swelling in the joints, brain or other areas. Scientists long have believed that cytokines use one cellular pathway in their response to infection, meaning that drugs made to block cytokines from causing inflammation also block the immune system and the ability to kill invading bugs.

In a study with mice, Li and his research colleagues upended the one-pathway belief by showing that cytokines use not one but two cellular pathways to battle infection: one to turn on the immune system and kill intruders and a separate one that destroys the architecture of tissues and organs. Identifying the separate pathway for inflammation has vast potential for developing drugs. "We can selectively block inflammation without making the patient immunosuppressed," Li says. "This rewrites the strategy for today's medicines. We focused the work on arthritis given this is a proven market for drugs that reduce damage from inflammation and fibrosis, but we suspect that many other diseases ranging from fibrosis following heart attacks to inflammatory bowel disease may benefit from such an approach."

Li's discovery has dramatic implications for the field of rheumatology, according to Tracy M. Frech, M.D., U of U assistant professor of internal medicine who specializes in rheumatology. "This may lead to more effective treatments for conditions such as lupus, systemic sclerosis, and the spectrum of inflammatory arthritis, without putting patients at risk for infections," she says. "This phenomenal work is a credit to the strong molecular medicine program here at the University of Utah."

Before a new generation of anti-inflammation drugs can be made, researchers must screen for molecules of chemical compounds that can be turned in pharmaceutical-grade drugs, something the University can and should do, according to Li. This can be accomplished either through collaboration with pharmaceutical companies outside of the state or with sources inside Utah, such as the USTAR initiative.

This study was funded by NIH grants:

#R01HL068873
#R01HL077671
#U54AI065357

Phil Sahm | EurekAlert!
Further information:
http://www.hsc.utah.edu

More articles from Health and Medicine:

nachricht Penn study identifies viral product that promotes immune defense against RSV
04.09.2015 | University of Pennsylvania

nachricht Columbia Engineering team develops targeted drug delivery to lung
03.09.2015 | Columbia University School of Engineering and Applied Science

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoperlen für die Stahlschmiede

Stahl gibt es seit rund 3000 Jahren und heute sogar in mehreren Tausend Variationen, und trotzdem ist er immer wieder für Überraschungen gut. Wissenschaftler des Max-Planck-Instituts für Eisenforschung in Düsseldorf haben in einem manganhaltigen Stahl nun beobachtet, dass die Legierung an linienförmigen Defekten eine andere Kristallstruktur bildet, als sie typisch ist für das Material. Sie berichten darüber im Fachjournal Science. Da sich die Länge der Liniendefekte in einem Kubikmeter Stahl auf ein Lichtjahr summieren kann, dürfte die Entdeckung große praktische Bedeutung haben. Denn von der Mikrostruktur eines Stahls hängen auch seine Eigenschaften ab.

Versetzungen können Leben retten. Solche Liniendefekte, genauer gesagt Stufenversetzungen entstehen, wenn eine Atomlage eines Kristalls unvollständig bleibt,...

Im Focus: LARA - Luftgekühlter Radnabenmotor mit hoher Drehmomentdichte auf Basis gegossener Aluminiumspulen

LARA umfasst die Entwicklung, Fertigung und Erprobung eines robusten luftgekühlten Radnabenmotors mit hoher Drehmomentdichte. Dieser kommt als Direktantrieb an allen vier Rädern eines leichten Stadtfahrzeugs als Demonstrator zum Einsatz. Wesentliche Herausforderung ist, das für die Fahrzeugnutzung im urbanen Umfeld notwendige Drehmoment bei hohen Wirkungsgraden aufzubringen und zugleich eine technologisch einfache Luftkühlung zur Abführung der thermischen Verlustleistungen umzusetzen.

Für die Wicklung des Elektromotors werden die vom Fraunhofer IFAM entwickelten gegossenen Spulen mit maximalem Nutfüllgrad eingesetzt, die zur Minimierung von...

Im Focus: Hubble survey unlocks clues to star birth in neighboring galaxy

In a survey of NASA's Hubble Space Telescope images of 2,753 young, blue star clusters in the neighboring Andromeda galaxy (M31), astronomers have found that M31 and our own galaxy have a similar percentage of newborn stars based on mass.

By nailing down what percentage of stars have a particular mass within a cluster, or the Initial Mass Function (IMF), scientists can better interpret the light...

Im Focus: Fraunhofer ISE entwickelt hochkompakten Wechselrichter für unterbrechungsfreie Stromversorgungen

Bauteile aus Siliziumkarbid ermöglichen Wirkungsgrad von 98,7 Prozent

Forscher des Fraunhofer-Instituts für Solare Energiesysteme ISE haben einen hochkompakten und -effizienten Wechselrichter für die unterbrechungsfreie...

Im Focus: Fraunhofer ISE Develops Highly Compact Inverter for Uninterruptible Power Supplies

Silicon Carbide Components Enable Efficiency of 98.7 percent

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE have developed a highly compact and efficient inverter for use in uninterruptible power...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

HMI 4.0 in mobilen Arbeitsmaschinen

04.09.2015 | Veranstaltungen

Innovative Citizen – Festival für neue urbane Fertigkeiten

04.09.2015 | Veranstaltungen

Seilroboter mit Passagier

04.09.2015 | Veranstaltungen

 
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

HMI 4.0 in mobilen Arbeitsmaschinen

04.09.2015 | Veranstaltungsnachrichten

Hinweise auf mikrobielles Leben im Erdmantel unterhalb des Meeresbodens entdeckt

04.09.2015 | Biowissenschaften Chemie

Gleichgewichtsorgan - Flexibler Sensor

04.09.2015 | Biowissenschaften Chemie